Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • THERAVANCE INC Earnings Analysis

  • Earnings Summary: THRX

    EPS (TTM): -1.26 Current P/E Ratio: -11.61905
    Last Quarter's Earnings: -0.35 Current Quarter Estimate: -0.327
    Last Fiscal Year Earnings: -1.53 Next Fiscal Year Estimate: -1.116
    Analyst Consensus: Hold Dividend Rate: 0.00
    Last Dividend: 0.00
  • Reported Quarters: THRX

    Quarterly EPS millions
  • Seasonal Performance: THRX

  • Conference Calls and Investor Events

    Upcoming Event(s)

    Fiscal Year End: December
    Date Time(ET) Upcoming Events Set Alert
    02/12/2010 * 18:00 Q4 2009 Theravance Inc. Earnings Release
    11/12/2009 18:30 Theravance Inc. at Credit Suisse Healthcare Conference

    Previous Event(s)

    Date Previous Event Listen Transcript/Brief
    10/27/2009 Q3 2009 Theravance Inc. Earnings Conference Call Download($)
    10/27/2009 Q3 2009 Theravance Inc. Earnings Release
    09/23/2009 Theravance Inc. at UBS Global Life Sciences Conference Download($)
    09/22/2009 Theravance Inc. at Bank of America Securities Smid Cap Conference Download($)
    09/17/2009 Theravance Inc. at Think Equity Growth Conference
    09/15/2009 Theravance Inc. at Morgan Stanley Global Healthcare Conference
    09/14/2009 Theravance and Astellas Announce FDA Approval of VIBATIV(TM) (telavancin) for the Treatment of Complicated Skin and Skin Structure Infections Download($)
    09/10/2009 Theravance Inc. at Robert W. Baird & Co., Inc. Health Care Conference
    09/09/2009 Theravance Inc. at Thomas Weisel Partners Healthcare Conference
    07/23/2009 Q2 2009 Theravance Inc. Earnings Conference Call Download($)
    07/23/2009 Q2 2009 Theravance Inc. Earnings Release
    * This event time is tentative